Linking GATA-3 and interleukin-13: Implications in asthma

Inflammation Research

Volumn 63, Issue 4, 2014, Pages 255-265

  Rayees, Sheikh ^a   Malik, Fayaz ^b   Bukhari, Syed Imran ^c   Singh, Gurdarshan ^a  

^a CSIR INDIAN INSTITUTE OF INTEGRATIVE MEDICINE   (India)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF JAMMU   (India)

Author keywords

Airway hypersensitivity; Asthma; Eosinophils; GATA3; IL 13; Lymphocytes

Indexed keywords

ANRUKINZUMAB; BRONCHODILATING AGENT; EOTAXIN; ESSENTIAL AMINO ACID; IMA 026; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G ANTIBODY; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 4; LEUKOTRIENE RECEPTOR BLOCKING AGENT; MEPOLIZUMAB; STAT4 PROTEIN; TRALOKINUMAB; TRANSCRIPTION FACTOR GATA 3; UNCLASSIFIED DRUG;

ALLERGIC AIRWAY INFLAMMATION; ALLERGIC ASTHMA; CYTOKINE PRODUCTION; DISEASE COURSE; EOSINOPHILIA; FIBROSIS; FORCED EXPIRATORY VOLUME; GENE EXPRESSION REGULATION; HUMAN; IMMUNOGLOBULIN PRODUCTION; IMMUNOPATHOGENESIS; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; MUCUS SECRETION; PATHOPHYSIOLOGY; PROTEIN DOMAIN; PROTEIN STRUCTURE; RESPIRATORY TRACT ALLERGY; REVIEW; TH2 CELL; TRANSCRIPTION REGULATION;

ANIMALS; ASTHMA; CELL DIFFERENTIATION; GATA3 TRANSCRIPTION FACTOR; HUMANS; INTERLEUKIN-13; TH2 CELLS;

EID: 84896545535     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0700-6     Document Type: Review

References (114)

1. Walsh GM, McDougall CM. The resolution of airway inflammation in asthma and COPD. In: Rossi AG, Sawatzky D, editors. Progress in inflammation research. Basel: Birkhauser Verlag A.G; 2007. p. 159-191.
2. Braman SS. The global burden of asthma. Chest. 2006;130:4S-12S. (Pubitemid 44107231)
3. McGrath KW, Icitovic N, Boushey HA, Lazarus SC, Sutherland ER, Chinchilli VM, Fahy JV. A large subgroup of mild-to-moderate asthma is persistently noneosinophilic. Am J Respir Crit Care. 2012;185:612-9.
4. Anderson GP. Endotyping asthma: new insights into key pathogenic mechanisms in a complex, heterogeneous disease. Lancet. 2008;372:1107-19.
5. Tattersfield AE, Knox AJ, Britton JR, Hall IP. Asthma. Lancet. 2002;360:1313-22. (Pubitemid 35284626)
6. Barnes PJ. Pathophysiology of asthma. Eur Respir Mon. 2003;8:84-113.
7. Payne DN, Rogers AV, Adelroth E, Bandi V, Guntupalli KK, Bush A, Jeffery PK. Early thickening of the reticular basement membrane in children with difficult asthma. Am J Respir Crit Care Med. 2003;167:78-82. (Pubitemid 36015921)
8. Allen D, Adinoff MD, Roger J, Hollister MD. Steroid-induced fractures and bone loss in patients with asthma. N Engl J Med. 1983;309:265-8.
9. Sont JK, Han J, van-Krieken JM, et al. Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids. Thorax. 1996;51:496-502. (Pubitemid 26160470)
10. Silverman AB. Treatment of steroid dependent asthmatics, US 5405842 A. 1995; 08/187, 915.
11. Comet R, Domingo C, Larrosa M, Morón A, Rué M, Amengual MJ, Marín A. Benefits of low weekly doses of methotrexate in steroid-dependent asthmatic patients. A double-blind, randomized, placebo-controlled study. Respir Med. 2006;100:411-9. (Pubitemid 43239875)
12. Haldar P, Brightling CE, Hargadon B. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med. 2009;360:973-84.
13. Kraft M. Asthma phenotypes and interleukin-13 - moving closer to personalized medicine. N Engl J Med. 2011;365:1141-4.
14. Antoniu SA, Pitrakinra A. Dual IL-4/IL-13 antagonist for the potential treatment of asthma and eczema. Curr Opin Invest Drugs. 2010;11:1286-94.
15. Woodruff PG, Modrek B, et al. T-helper type 2 - driven inflammation defines major subphenotypes of asthma. Am J Respir Crit Care Med. 2009;180:388-95.
16. Singh D, Richards D, Knowles RG, Schwartz S, Woodcock A, Langley S, O'Connor BJ. Selective Inducible nitric oxide synthase inhibition has no effect on allergen challenge in asthma. Am J Respir Crit Care Med. 2007;176:988-93. (Pubitemid 350127842)
17. Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA. 2007;2:15858-63. (Pubitemid 350035389)
18. Wochnik GM, Rüegg J, Abel GA, Schmidt U, Holsboer F, Rein T. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells. J Biol Chem. 2005;280:4609-16. (Pubitemid 40288629)
19. Denny WB, Valentine DL, Reynolds PD, Smith DF, Scammell JG. Squirrel monkey immunophilin FKBP51 is a potent inhibitor of glucocorticoid receptor binding. Endocrinology. 2000;141:4107-13.
20. Caramori G, Groneberg D, Ito K, Casolari P, Adcock IM, Papi A. New drugs targeting Th2 lymphocytes in asthma. J Occup Med Toxicol. 2008;3:1-6.
21. Stephen TH, Riccardo P. Treatment strategies for allergy and asthma. Nat Rev Immunol. 2008;8:218-30.
22. Morrisey EE, Ip HS, Lu MM, Parmacek MS. GATA-6: a zinc finger transcription factor that is expressed in multiple cell lineages derived from lateral mesoderm. Dev Biol. 1996;177:309-22. (Pubitemid 26252501)
23. Arceci RJ, King AA, Simon MC, Orkin SH, Wilson DB. Mouse GATA-4: a retinoic acid-inducible GATA-binding transcription factor expressed in endodermally derived tissues and heart. Mol Cell Biol. 1993;13:2235-46. (Pubitemid 23097702)
24. Ho IC, Vorhees P, Marin N, Oakley BK, Tsai SF, Orkin SH, Leiden JM. Human GATA-3: a lineage-restricted transcription factor that regulates the expression of the T cell receptor alpha gene. EMBO J. 1991;10:1187-92. (Pubitemid 21905580)
25. Oosterwegel M, Timmerman J, Leiden J, Clevers H. Expression of GATA-3 during lymphocyte differentiation and mouse embryogenesis. Dev Immunol. 1992;3:1-11.
26. Samson SI, Richard O, Tavian M, Ranson T, Vosshenrich CA, Colucci F, Buer J, Grosveld F, Godin I, Di-Santo JP. GATA-3 promotes maturation. IFN-γ production and liver-specific homing of NK cells. Immunity. 2003;19:701-11. (Pubitemid 37490795)
27. O'Garra A. Cytokines induce the development of functionally heterogeneous T helper cell subsets. Immunity. 1998;8:275-83. (Pubitemid 28188888)
28. Murphy KM, Ouyang W, Farrar JD, Yang J, Ranganath S, Asnagli H, Afkarian M, Murphy TL. Signaling and transcription in T helper development. Annu Rev Immunol. 2000;18:451-94. (Pubitemid 30365388)
29. Glimcher LH, Murphy KM. Lineage commitment in the immune system: the T helper lymphocyte grows up. Genes Dev. 2000;14:1693-711. (Pubitemid 30602989)
30. Wynn TA. IL-13 effector functions. Annu Rev Immunol. 2003;21:425-56. (Pubitemid 37174537)
31. Wills-Karp M. Interleukin-13 in asthma pathogenesis. Immunol Rev. 2004;202:175-90. (Pubitemid 39576912)
32. Caramori G, Lim S, Ito K, Tomita K, Oates T, Jazrawi E, Chung KF, Barnes PJ, Adcock IM. Expression of GATA family of transcription factors in T-cells, monocytes and bronchial biopsies. Eur Respir J. 2001;18:466-73. (Pubitemid 32895631)
33. + regulatory T cell fate during inflammation in mice. J Clin Invest. 2011;121:4503-15.
34. Usui T, Nishikomori R, Kitani A, Strober W. GATA-3 suppresses Th1 development by downregulation of Stat4 and not through effects on IL-12R beta2 chain or T-bet. Immunity. 2003;18:415-28. (Pubitemid 36351520)
35. Ouyang W, Ranganath SH, Weindel K, Bhattacharya D, Murphy TL, Sha WC, Murphy KM. Inhibition of Th1 development mediated by GATA-3 through an IL-4-independent mechanism. Immunity. 1998;9:745-55. (Pubitemid 28557602)
36. Ray A, Cohn L. Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation. J Clin Invest. 1999;104:985-93. (Pubitemid 29536304)
37. McLane MP, Haczku A, Van-de-Rijn M, Weiss C, Ferrante V, MacDonald D, McLane MP, Haczku A, Van-de-Rijn M, Weiss C, Ferrante V, MacDonald D, Renauld JC, Nicolaides NC, Holroyd KJ, Levitt RC. Interleukin-9 promotes allergen-induced eosinophilic inflammation and airway hyper responsiveness in transgenic mice. Am J Respir Cell Mol Biol. 1998;19:713-20. (Pubitemid 128353670)
38. Yao X, Zha W, Song W, et al. Coordinated regulation of IL-4 and IL-13 expression in human T cells: 3C analysis for DNA looping. Biochem Biophys Res Commun. 2012;417:996-1001.
39. Jee YK, Gilmour J, Kelly A, et al. Repression of interleukin-5 transcription by the glucocorticoid receptor targets gata3 signaling and involves histone deacetylase recruitment. J Boil Chem. 2005;280:23243-50. (Pubitemid 40853236)
40. Grogan JL, Mohrs M, Harmon B, Lacy DA, Sedat JW, Locksley RM. Early transcription and silencing of cytokine genes underlie polarization of T helper cell subsets. Immunity. 2001;14:205-15. (Pubitemid 32289286)
41. Yamane H, Zhu J, Paul WE. Independent roles for IL-2 and GATA-3 in stimulating naive CD4 + T cells to generate a Th2-inducing cytokine environment. J Exp Med. 2005;202:793-804. (Pubitemid 41345968)
42. Avni O, Lee D, Macian F, Szabo SJ, Glimcher LH, Rao A. TH cell differentiation is accompanied by dynamic changes in histone acetylation of cytokine genes. Nat Immunol. 2002;3:643-51. (Pubitemid 34752473)
43. Lee GR, Fields PE, Flavell RA. Regulation of IL-4 gene expression by distal regulatory elements and GATA-3 at the chromatin level. Immunity. 2001;14:447-59. (Pubitemid 32441597)
44. Ouyang W, Löhning M, Gao Z, Assenmacher M, Ranganath S, Radbruch A, Murphy KM. Stat6-independent GATA-3 autoactivation directs IL-4-independent Th2 development and commitment. Immunity. 2007;12:27-37.
45. Amsen D, Antov A, Jankovic D, Sher A, Radtke F, Souabni A, Busslinger M, McCright B, Gridley T, Flavell RA. Direct regulation of Gata3 expression determines the T helper differentiation potential of Notch. Immunity. 2007;27:89-99. (Pubitemid 47096801)
46. Fang TC, Yashiro-Ohtani Y, Bianco CD, Knoblock DM, Blacklow SC, Pear WS. Notch directly regulates Gata3 expression during T helper 2 cell differentiation. Immunity. 2007;27:100-10. (Pubitemid 47096803)
47. Asnagli H, Afkarian M, Murphy KM. Cutting edge: identification of an alternative GATA-3 promoter directing tissue-specific gene expression in mouse and human. J Immunol. 2002;168:4268-71. (Pubitemid 34441323)
48. Zhu J, Cote-Sierra J, Guo L, Paul WE. Stat5 activation plays a critical role in Th2 Differentiation. Immunity. 2003;19:739-48. (Pubitemid 37490798)
49. Cote-Sierra J, Foucras G, Guo L, Chiodetti L, Young HA, Hu-Li J, Zhu J, Paul WE. Interleukin 2 plays a central role in Th2 differentiation. Proc Natl Acad Sci. 2004;101:3880-5. (Pubitemid 38381071)
50. Piper Edward, Brightling Christopher, Niven Robert, et al. A phase II placebo-controlled study of tralokinumab in moderate-to-severe asthma. Eur Respir J. 2013;41:330-8.
51. Gauvreau GM, Boulet LP, Cockcroft DW, et al. Effects of interleukin-13 blockade on allergen-induced airway responses in mild atopic asthma. Am J Respir Crit Care Med. 2011;183: 1007-14.
52. Pueringer RJ, Hunninghake GW. Inflammation and airway reactivity in asthma. Am J Med. 1992;92:32S-8S.
53. White MV. Nasal cholinergic hyper responsiveness in atopic subjects studied out of season. J Allergy Clin Immunol. 1993;92: 278-87. (Pubitemid 23254116)
54. Grunig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, Sheppard D, Mohrs M, Donaldson DD, Locksley RM, Corry DB. Requirement for IL-13 independently of IL-4 in experimental asthma. Science. 1998;282:2261-3. (Pubitemid 29004075)
55. Karp MW, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, Donaldson DD. Interleukin-13: central mediator of allergic asthma. Science. 1998;282:2258-61. (Pubitemid 29004074)
56. Haczku A, Cao Y, Vass G, Kierstein S, Nath P, Atochina-Vasserman EN, Scan-lon ST, Li L, Griswold DE, Chung KF, Poulain FR, Hawgood S, Beers MF, Crouch EC. IL-4 and IL-13 form a negative feedback circuit with surfactant protein-D in the allergic airway response. J Immunol. 2006;176:3557-65. (Pubitemid 43364003)
57. Madan T, Reid KB, Singh M, Sarma PU, Kishore U. Susceptibility of mice genetically deficient in the surfactant protein (SP)-A or SP-D gene to pulmonary hypersensitivity induced by antigens and allergens of Aspergillus fumigates. J Immunol. 2005;174:6943-54. (Pubitemid 40705659)
58. Walter DM, McIntire JJ, Berry G, McKenzie AN, Donaldson DD, DeKruyff RH, Umetsu DT. Critical role for IL-13 in the development of allergen-induced airway hyperreactivity. J Immunol. 2001;167:4668-75. (Pubitemid 32954348)
59. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K, Umeshita R, Abe Y, Braun S, Yamashita T, Roberts MH, Sugimoto R, Arima K, Arinobu Y, Yu B, Kruse S, Enomoto T, Dake Y, Kawai M, Shimazu S, Sasaki S, Adra CN, Kitaichi M, Inoue H, Yamauchi K, Tomichi N, Kurimoto F, Hamasaki N, Hopkin JM, Izuhara K, Shirakawa T, Deichmann KA. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet. 2000;9:549-59. (Pubitemid 30154013)
60. Eum SY, Maghni K, et al. IL-13 may mediate allergen-induced hyperresponsiveness independently of IL-5 or eotaxin by effects on airway smooth muscle. Am J Physiol Lung Cell Mol Physiol. 2005;288:576-84.
61. Walsh GM. Novel cytokine-directed therapies for asthma. Discov Med. 2011;11:283-91.
62. Fallon PG, Emson CL, Smith P, McKenzie AN. IL-13 over expression pre-disposes to anaphylaxis following antigen sensitization. J Immunol. 2001;166:2712-6. (Pubitemid 32173512)
63. McKenzie GJ, Emson CL, Bell SE, Anderson S, Fallon P, Zurawski G, Murray R, Grencis R, McKenzie AN. Impaired development of Th2 cells in IL-13-deficient mice. Immunity. 1998;9:423-32. (Pubitemid 28462763)
64. Webb DC, McKenzie AN, Koskinen AM, Yang M, Mattes J, Foster PS. Integrated signals between IL-13, IL-4, and IL-5 regulate airways hyperreactivity. J Immunol. 2000;165:108-13. (Pubitemid 30429497)
65. Taube C, Duez C, Cui ZH, Takeda K, Rha YH, Park JW, Balhorn A, Donaldson DD, Dakhama A, Gelfand EW. The role of IL-13 in established allergic airway disease. J Immunol. 2002;169:6482-9. (Pubitemid 36903499)
66. Luttmann W, Knoechel B, Foerster M, Matthys H, Virchow JC, Kroegel C. Activation of human eosinophils by IL-13. Induction of CD69 surface anti-gen, its relationship to messenger RNA expression, and promotion of cellular viability. J Immunol. 1996;157:1678-83. (Pubitemid 126449110)
67. Pope SM, Brandt EB, Mishra A, Hogan SP, Zimmermann N, Matthaei KI, Foster PS, Rothenberg ME. IL-13 induces eosinophil recruitment into the lung by an IL-5- and eotaxin-dependent mechanism. J Allergy Clin Immunol. 2001;108:594-601. (Pubitemid 32978032)
68. Lam KP, Chu YT, Lee MS, Chen HN, Wang WL, Tok TS, Chin YY, Chen SC, Kuo CH, Hung CH. Inhibitory effects of albuterol and fenoterol on RANTES and IP-10 expression in bronchial epithelial cells. Pediatr Allergy Immunol. 2011;22:431-9.
69. Tomasiak-Łozowska MM, Bodzenta-Łukaszyk A, Tomasiak M, Skiepko R, Zietkowski Z. The role of interleukin 13 and interleukin 5 in asthma. Postepy Hig Med Dosw. 2010;19:146-55.
70. Taku K, Kiyosh T. IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol. 2009;21:1303-9.
71. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, Azzarone B. Interleukin (IL) 4 and IL-13 act on human lung fibroblasts implication in asthma. J Clin Invest. 1998;101:2129-39. (Pubitemid 28244097)
72. Fulkerson PC, Fischetti CA, Hassman LM, Nikolaidis NM, Rothenberg ME. Persistent effects induced by IL-13 in the lung. Am J Respir Cell Mol Biol. 2006;35:337-46. (Pubitemid 44353402)
73. Blease K, Schuh JM, Jakubzick C, Lukacs NW, Kunke SL, Joshi BH, et al. Stat6-deficient mice develop airway hyperresponsiveness and peribronchial fibrosis during chronic fungal asthma. Am J Pathol. 2002;160:481-90. (Pubitemid 34160325)
74. Kumar RK, Herbert C, Yang M, Koskinen AM, McKenzie AN, Foster PS. Role of interleukin-13 in eosinophil accumulation and airway remodelling in a mouse model of chronic asthma. Clin Exp Allergy. 2002;32:1104-11. (Pubitemid 34779610)
75. Vercelli D, Jabara HH, Arai KI, Geha RS. Induction of human IgE synthesis requires interleukin 4 and T/B interactions involving the T cell receptor/CD3 complex and MHC class II antigens. J Exp Med. 1989;169:1295-307. (Pubitemid 19104963)
76. Punnonen J, Aversa G, Cocks BG, McKenzie ANJ, Menon S, Zurawski G. Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci. 1993;90:3730-4. (Pubitemid 23111441)
77. Punnonen J, Cocks BG, De Vries JE. IL-4 induces germ-line IgE heavy chain gene transcription in human fetal pre-B cells. Evidence for differential expression of functional IL-4 and IL-13 receptors during B cell ontogeny. J Immunol. 1995;155:4248-54.
78. Whittaker L, Niu N, Temann UA, Stoddard A, Flavell RA, Ray A. Interleukin-13 mediates a fundamental pathway for airway epithelial mucus induced by CD4 T cells and interleukin-9. Am J Respir Cell Mol Biol. 2002;27:593-602. (Pubitemid 35301814)
79. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med. 2002;8:885-9.
80. Atherton HC, Jones G, Danahay H. IL-13-induced changes in the goblet cell density of human bronchial epithelial cell cultures: MAP kinase and phosphatidylinositol 3- kinase regulation. Am J Physiol Lung Cell Mol Physiol. 2003;285:730-9.
81. Finkelman FD, Yang M, Perkins C, Schleifer K, Sproles A, Santeliz J. Suppressive effect of IL-4 on IL-13-induced genes in mouse lung. J Immunol. 2005;174:4630-8.
82. Ramalingam TR, Pesce JT, Sheikh F, Cheever AW, Mentink-Kane MM, Wilson MS. Unique functions of the type II interleukin 4 receptor identified in mice lacking the interleukin 13 receptor alpha1 chain. Nat Immunol. 2008;9:25-33. (Pubitemid 350286200)
83. Cohn L, Elias JA, Chupp GL. Asthma: mechanisms of disease persistence and progression. Ann Rev Immunol. 2004;22:789-815. (Pubitemid 38680442)
84. Hohlfeld JM, Erpenbeck VJ, Krug N. Surfactant proteins SP-A and SP-D as modulators of the allergic inflammation in asthma. Pathobiology. 2002;70:287-92. (Pubitemid 36682976)
85. Aman MJ, Tayebi N, Obiri NI, et al. cDNA cloning and characterization of the human interleukin 13 receptor αchain. J Biol Chem. 1996;271:29265-70. (Pubitemid 26382639)
86. Miloux B, Laurent P, Bonnin O, et al. Cloning of the human IL-13Rα1 chain and reconstitution with the IL4Rα of a functional IL-4/IL-13 receptor complex. FEBS Lett. 1997;401:163-6. (Pubitemid 27056108)
87. Donaldson DD, Whitters MJ, Fitz LJ. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J Immunol. 1998;161:2317-24. (Pubitemid 28397044)
88. Homer RJ, Zheng T, Chupp G, He S, Zhu Z, Chen Q, Ma B, Hite RD, Gobran LI, Rooney SA, Elias JA. Pulmonary type II cell hypertrophy and pulmonary lipoproteinosis are features of chronic IL-13 exposure. Am J Physiol Lung Cell Mol Physiol. 2002;283:52-9.
89. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, Zhang Y, Elias JA. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest. 1999;103:779-88. (Pubitemid 29152623)
90. Zhou M, Ouyang W. The function role of GATA-3 in Th1 and Th2 Differentiation. Immunol Res. 2003;28:25-37. (Pubitemid 37088540)
91. Chou J, Provot S, Werb Z. GATA3 in development and cancer differentiation: cells GATA have it. J Cell Physiol. 2010;222:42-9.
92. Rothenberg EV, Moore JE, Yui MA. Launching the T-cell lineage developmental programme. Nat Rev Immunol. 2008;8:9-21.
93. Ho IC, Tai TS, Pai SY. GATA3 and the T-cell lineage: essential functions before and after T-helper-2-cell differentiation. Nat Rev Immunol. 2009;9:125-35.
94. Ansel KM, Djuretic I, Tanasa B, Rao A. Regulation of Th2 differentiation and IL-4 locus accessibility. Ann Rev Immunol. 2006;24:607-56.
95. Nakayama T, Yamashita M. Initiation and maintenance of Th2 cell identity. Curr Opin Immunol. 2008;20:265-71.
96. Kishikawa H, Sun J, Choi A, Miaw SC, Ho IC. The cell type specific expression of the murine IL-13 gene is regulated by GATA-3. J Immunol. 2001;167:4414-20. (Pubitemid 32954318)
97. Maurice D, Hooper J, Lang G, Weston K. c-Myb regulates lineage choice in developing thymocytes via its target gene Gata3. EMBO J. 2007;26:3629-40. (Pubitemid 47236884)
98. Pai SY. Distinct structural requirements of GATA-3 for the regulation of thymocyte and Th2 cell differentiation. J Immunol. 2008;180:1050-9.
99. Zhao X. Interaction between GATA-3 and the transcriptional co regulator Pias1 is important for the regulation of Th2 immune responses. J Immunol. 2007;179:8297-304.
100. Zurawski G, de Vries JE. Interleukin 13, an interleukin-4 like cytokine that acts on monocytes and B cells, but not on T cells. Immunol Today. 1994;15:19-26.
101. Woerly G, Lacy P, Younes AB. Human eosinophils express and release IL-13 following CD28-dependent activation. Jour Leukoc Biol. 2002;72:769-79. (Pubitemid 36277849)
102. Akbari O, Stock P, Meyer E. Essential role of NKT cells producing IL-4 and IL-13 in the development of allergen-induced airway hyperreactivity. Nat Med. 2003;9:582-8. (Pubitemid 36597105)
103. Guo L, Wei G, Zhu J, Liao W, Leonard WL, Zhao K, Paul W. IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. PNAS. 2009;106:13463-8.
104. Chang YJ, Kim HY, Albacker LA, et al. Innate lymphoid cells mediate influenza-induced airway hyper-reactivity independently of adaptive immunity. Nat Immunol. 2011;12:631-8.
105. Mjosberg JM, Trifari S, Crellin NK, et al. Human IL-25- and IL-33-responsive type 2 innate lymphoid cells are defined by expression of CRTH2 and CD161. Nat Immunol. 2011;12:1055-62.
106. Klein-Wolterink RG, Serafini N, van Nimwegen M, et al. Essential, dose-dependent role for the transcription factor Gata3 in the development of IL-5+ and IL-13+ type 2 innate lymphoid cells. Proc Natl Acad Sci USA. 2013;110:10240-1025.
107. Zhang DH, Yang L, Cohn L. Inhibition of allergic inflammation in a murine model of asthma by expression of a dominant negative mutant of GATA-3. Immunity. 1999;11:473-82. (Pubitemid 29504202)
108. Takemoto N, Kamogawa Y, Jun-Lee H, Kurata H, Arai KI. A O'Garra, N Arai, S Miyatake, Chromatin remodeling at the IL-4/IL-13 intergenic regulatory region for Th2-specific cytokine gene cluster. J Immunol. 2000;165:6687-91. (Pubitemid 32001130)
109. Lee HJ, Takemoto N, Kurata HY, et al. GATA-3 induces T helper cell type 2 (Th2) cytokine expression and chromatin remodeling in committed Th1 cells. J Exp Med. 2000;192:105-15. (Pubitemid 30470811)
110. Cecile LB, Cecelia DT, Iman M, Paul-Henri R, Max-Audit I. Interleukin-13 gene expression is regulated by gata-3 in T cells. J Biol Chem. 2002;277:18313-21.
111. Zhang DH, Yang L, Ray A. Differential responsiveness of the IL-5 and IL-4 genes to transcription factor GATA-3. J Immunol. 1998;161:3817-21. (Pubitemid 28468953)
112. Yamashita M, Ukai-Tadenuma M, Kimura M. Identification of a conserved GATA3 response element upstream proximal from the interleukin-13 gene locus. J Biol Chem. 2002;277:42399-408. (Pubitemid 35257563)
113. Maneechotesuwan K, Xin Y, Ito K, et al. Regulation of Th2 cytokine genes by p38 MAPK-mediated phosphorylation of GATA-3. J Immunol. 2007;178:2491-8. (Pubitemid 46233450)
114. Nakamura Y, Hoshino M. Th2 cytokines and associated transcription factors as therapeutic targets in asthma. Curr Drug Targets Inflamm Allergy. 2005;4:267-70. (Pubitemid 40873109)